Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
29 results
D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria
D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap
D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment
D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases
D1.506 - Mast cell activation and type 2 inflammation in heart failure with preserved ejection fraction: a pilot cross-sectional study
D1.508 - Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis
D1.510 - Fecal Calprotectin as a Marker for Differentiating Children with Atopic Dermatitis With and Without Food Allergy
D1.511 - Hereditary alpha-tryptasemia in chronic spontaneous urticaria: prevalence and clinical impact
D1.513 - Reduced Expression of PDCD4 on CD14+ Monocytes Correlates with Inflammatory Severity in Neonatal Sepsis: A Pilot Study
D3.370 - Three cases of erdosteine-induced delayed drug hypersensitivity
D3.373 - Non-immediate Hypersensitivity Reactions To Both Penicillin and Aminopenicillin and Diagnostic approach – A Real Life Retrospective Study
D3.372 - Rapid Intramuscular Penicillin Desensitization: A Promising Future
D3.374 - Recall urticaria to dalteparin sodium in a patient with previous systemic reaction to nadroparin calcium
D3.375 - Delayed-Type Drug Reactions in Pediatric Patients: Clinical Features and Management
D3.376 - Drug Allergy Related to Chemotherapy and Premedication: Anaphylaxis Induced by Carboplatin and Methylprednisolone
D3.378 - Drug hypersensitivity in children in a frontline setting: interim results of a pilot epidemiological project
D3.380 - The Most Serious Threat in Perioperative Hypersensitivity Reactions (PHRs): Neuromuscular Blocking Agent (NMBA) Hypersensitivity and Cisatracurium as a Safe Haven in the Setting of Cross-Reactivity
D3.381 - The paradox of treatment: H1-antihistamines-induced urticaria in a patient with chronic spontaneous urticaria
D3.382 - Safety and outcomes of penicillin desensitization during pregnancy: experience from a tertiary referral center
D3.383 - Delayed T-cell–mediated hypersensitivity to dimethyl fumarate: clinical presentation and diagnostic considerations
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download